|
||
By

From the * Department of Pediatrics, Program in Molecular Medicine, University of Massachusetts
Medical Center, Worcester, Massachusetts 01605; and High frequencies of cytotoxic T lymphocyte precursors (CTLp) recognizing HIV-1 laboratory
strain gene products have been detected in adults within weeks of primary infection. In contrast, HIV-1-specific CTLp are uncommonly detected in infants younger than 6 mo. To address the hypothesis that the use of target cells expressing laboratory strain env gene products
might limit the detection of HIV-1 env-specific CTLp in early infancy, recombinant vaccinia vectors (vv) expressing HIV-1 env genes from early isolates of four vertically infected infants
were generated. The frequencies of CTLp recognizing target cells infected with vv-expressing
env gene products from early isolates and HIV-1 IIIB were serially measured using limiting dilution followed by in vitro stimulation with mAb to CD3. In one infant, the detection of early
isolate env-specific CTLp preceded the detection of IIIB-specific CTLp. CTLp recognizing
HIV-1 IIIB and infant isolate env were detected by 6 mo of age in two infants. In a fourth infant, HIV-1 IIIB env and early isolate env-specific CTLp were simultaneously detected at 12 mo of
age. These results provide evidence that young infants can generate HIV-1-specific CTL responses and provide support for the concept of neonatal vaccination to prevent HIV-1 transmission. However, the early predominance of type-specific CTL detected in some young infants suggests that the use of vaccines based on laboratory strains of HIV-1 may not protect
against vertical infection.
Therion Biologics Corporation, Cambridge,
Massachusetts 02142
This article has been cited by other articles:
| TABLE OF CONTENTS |
|